Home > Boards > US Listed > Medical - Equipment > Obalon Therapeutics, Inc. (OBLN)

SAN DIEGO, Feb. 27, 2019 (GLOBE NEWSWIRE) --

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
r clarke Member Profile
 
Followed By 11
Posts 2,761
Boards Moderated 1
Alias Born 11/16/13
160x600 placeholder
Bariatric Medical Institute of Texas Presents Favorable Study Results for Obalon Balloon Administration Using Navigation Devi... GlobeNewswire Inc. - 6/24/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2019 6:02:09 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 6/21/2019 5:24:09 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/13/2019 4:08:23 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/13/2019 4:03:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 12:28:00 PM
Obalon Appoints Bob MacDonald as Chief Retail Officer GlobeNewswire Inc. - 6/10/2019 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/7/2019 5:05:43 PM
Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System GlobeNewswire Inc. - 6/4/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 7:16:25 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/3/2019 7:16:05 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 5/31/2019 5:31:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2019 5:12:26 PM
Under the Radar Biotechs To Research Now InvestorsHub NewsWire - 5/30/2019 1:40:00 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 5/30/2019 6:09:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/30/2019 6:05:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2019 5:23:42 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/28/2019 6:05:25 AM
Obalon Therapeutics, Inc. Prices $3,000,000 Registered Direct Offering GlobeNewswire Inc. - 5/23/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2019 4:52:11 PM
Expanded Clinical Data Set for the Obalon Balloon System Presented at DDW 2019 GlobeNewswire Inc. - 5/21/2019 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2019 4:03:47 PM
Obalon Announces Receipt of Delisting Notification Letters from Nasdaq GlobeNewswire Inc. - 5/17/2019 4:01:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 5:24:07 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2019 6:28:44 AM
r clarke   Tuesday, 03/05/19 09:38:42 PM
Re: None
Post # of 349 
SAN DIEGO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) announces the first commercial use of the Obalon Navigation System™ and Touch™ Inflation Dispenser for balloon administration. The Obalon Navigation System and Touch Inflation Dispenser are intended to improve the reliability and ease of balloon administration, and to reduce the costs and logistics for physicians to adopt the Obalon Balloon System as a non-surgical treatment for their patients with obesity.

Dr. Shawn Garber of New York Bariatric Group, who performed the first commercial administration using the Obalon Navigation System said, “We have made the Obalon Balloon a standard of care in my practice with outstanding outcomes for patients. The new Obalon Navigation System, which eliminates the need for x-ray, improves the ease of use and will allow us to now more easily and economically treat patients with systems at multiple sites.”

Kelly Huang, PhD, CEO of Obalon added, “We believe the Obalon Navigation System addresses the largest barrier for physician adoption and will allow us to further penetrate the significant potential market for patients with obesity. We remain dedicated to helping obese adults with a body mass index (BMI) of between 30 and 40 kg/m2 achieve effective weight loss to improve their health and increase their self-esteem.”

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist